Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.

Int J Mol Sci · 2023 · PMC10002358 · PMID 36901765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A phase II clinical trial including 110 participants treated intravenously with 3K3A-APC combined with thrombectomy, thrombolysis, or both showed a trend toward lower hemorrhage rate (RHAPSODY; NCT02222714 ) [ 27 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.